The Multicompartmental p32/gClqR as a New Target for Antibody-based Tumor Targeting Strategies
Authors:
- David Sánchez-MartínDSDavid Sánchez-Martín
- Ángel M. CuestaÁCÁngel M. Cuesta
- Valentina FogalVFValentina Fogal
- Erkki RuoslahtiERErkki Ruoslahti
- Luis Álvarez-VallinaLÁLuis Álvarez-Vallina
Open Access
- 1 February 2011
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (7) , 5197-5203
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Targeting of drugs and nanoparticles to tumorsJournal of Cell Biology, 2010
- C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetrationProceedings of the National Academy of Sciences, 2009
- In Vivo Tumor Targeting and Imaging with Engineered Trivalent Antibody Fragments Containing Collagen-Derived SequencesPLOS ONE, 2009
- Targeting of albumin-embedded paclitaxel nanoparticles to tumorsNanomedicine: Nanotechnology, Biology and Medicine, 2009
- Mitochondrial/Cell-Surface Protein p32/gC1qR as a Molecular Target in Tumor Cells and Tumor StromaCancer Research, 2008
- Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cellsBlood, 2001
- Kininogen binding protein p33/gC1qR is localized in the vesicular fraction of endothelial cellsFEBS Letters, 1996
- Human C1q Induces Eosinophil MigrationClinical Immunology and Immunopathology, 1996
- Identification of a gC1q-binding protein (gC1q-R) on the surface of human neutrophils. Subcellular localization and binding properties in comparison with the cC1q-R.Journal of Clinical Investigation, 1995
- Selection of phage antibodies by binding affinityJournal of Molecular Biology, 1992